全文获取类型
收费全文 | 19000篇 |
免费 | 1350篇 |
国内免费 | 91篇 |
专业分类
耳鼻咽喉 | 171篇 |
儿科学 | 385篇 |
妇产科学 | 326篇 |
基础医学 | 2428篇 |
口腔科学 | 220篇 |
临床医学 | 1816篇 |
内科学 | 4442篇 |
皮肤病学 | 313篇 |
神经病学 | 2033篇 |
特种医学 | 859篇 |
外科学 | 3081篇 |
综合类 | 126篇 |
一般理论 | 4篇 |
预防医学 | 1124篇 |
眼科学 | 243篇 |
药学 | 1248篇 |
中国医学 | 20篇 |
肿瘤学 | 1602篇 |
出版年
2023年 | 117篇 |
2022年 | 175篇 |
2021年 | 517篇 |
2020年 | 257篇 |
2019年 | 499篇 |
2018年 | 611篇 |
2017年 | 413篇 |
2016年 | 431篇 |
2015年 | 493篇 |
2014年 | 775篇 |
2013年 | 943篇 |
2012年 | 1479篇 |
2011年 | 1505篇 |
2010年 | 843篇 |
2009年 | 789篇 |
2008年 | 1225篇 |
2007年 | 1163篇 |
2006年 | 1213篇 |
2005年 | 1075篇 |
2004年 | 1035篇 |
2003年 | 876篇 |
2002年 | 850篇 |
2001年 | 245篇 |
2000年 | 220篇 |
1999年 | 214篇 |
1998年 | 170篇 |
1997年 | 153篇 |
1996年 | 126篇 |
1995年 | 118篇 |
1994年 | 114篇 |
1993年 | 77篇 |
1992年 | 145篇 |
1991年 | 121篇 |
1990年 | 124篇 |
1989年 | 111篇 |
1988年 | 139篇 |
1987年 | 90篇 |
1986年 | 97篇 |
1985年 | 76篇 |
1984年 | 69篇 |
1983年 | 71篇 |
1982年 | 38篇 |
1979年 | 40篇 |
1978年 | 39篇 |
1975年 | 49篇 |
1974年 | 63篇 |
1973年 | 49篇 |
1972年 | 42篇 |
1970年 | 40篇 |
1969年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
Christopher J. Destache David J. Guervil Keith S. Kaye 《International journal of antimicrobial agents》2019,53(5):644-649
Background
The clinical experience of ceftaroline fosamil (CPT-F) therapy for Gram-positive infective endocarditis is reported from CAPTURE, a retrospective study conducted in the USA.Methods
Data, including patient demographics, medical history, risk factors, microbiological aetiology and clinical outcomes, were collected by review of patient charts between September 2013 and February 2015.Results
Patients (n=55) with Gram-positive endocarditis were treated with CPT-F. The most common risk factors were intravascular devices (43.6%), diabetes mellitus (40.0%) and injection drug use (38.2%). The most commonly isolated pathogens were meticillin-resistant Staphylococcus aureus (MRSA; 80%), meticillin-susceptible S. aureus (MSSA; 7.3%) and coagulase-negative staphylococci (7.3%). CPT-F was given as first-line therapy in 7.3% of patients and as second-line or later therapy in 92.7% of patients, and as monotherapy in 41.8% of patients and as concurrent therapy in 58.2% of patients. Clinical success was observed in 82.6% (19/23) of patients treated with CPT-F as monotherapy. In patients treated with CPT-F as first-line therapy or second-line or later therapy, 75.0% (3/4) and 70.6% (36/51) achieved success, respectively. Clinical success was observed in 77.3% (34/44) of patients with MRSA and 25% (1/4) of patients with MSSA. Two patients discontinued treatment with CPT-F due to an adverse event.Conclusions
CPT-F treatment was associated with a high rate of clinical success in patients with Gram-positive infective endocarditis, including those with risk factors and infections caused by MRSA. A high rate of clinical success was observed in patients treated with CPT-F used as first- line therapy or second-line or later therapy, or as monotherapy or in combination with other antibiotics. 相似文献9.
Thierry Patrice David Olivier Ludovic Bourre 《Journal of environmental pathology, toxicology and oncology》2006,25(1-2):467-485
Photodynamic therapy (PDT) is based on the selective light activation of an exogenously given drug to patients. PDT acts mainly on cell membranes either of neovascular endothelial cells or of cancer cells leading to cancer cell death. Six drugs are now marketed based on clinical assays in various indications, which showed a clear cost efficiency as compared to other classical procedures. PDT is easy to handle and can be performed in medical installations fitting the conditions of health care in developing countries. Its cost effectiveness could represent an appropriate solution to the increasing number of cancers of various origin. However despite all the clinical results now available, PDT development remains slow. The reasons for this situation include cost of development, intellectual property, and competition between pharmaceutical companies. 相似文献
10.
Anne Pavy-Le Traon Richard L Hughson Claire Thalamas Monique Galitsky Nelly Fabre Olivier Rascol Jean-Michel Senard 《Movement disorders》2006,21(12):2122-2126
Patients with multiple system atrophy (MSA) present large changes in blood pressure (BP) due to autonomic disturbances. We analyzed how this change may influence dynamic cerebral autoregulation (DCA). Simultaneous recordings of arterial BP (Finapres) and middle cerebral artery (MCA) blood flow velocity (BFV) (transcranial Doppler) were performed in 10 patients with MSA (61 +/- 12 yr of age) and 12 healthy volunteers (61 +/- 11 yr of age): cerebral BFV response to oscillations in mean BP was studied in the supine position by cross-spectral analysis of mean BP and mean MCA BFV. The DCA was also studied during the decrease in BP the first seconds when standing up from a sitting position by the assessment of the cerebrovascular resistance index (CR; mean BP/mean MCA BFV ratio). The MCA BFV/BP cross-spectral analysis showed a phase for the mid-frequency band (0.07-0.2 Hz) significantly larger in MSA, suggesting more active autoregulation in response to larger changes in BP. Changes in CR reflecting the rate of autoregulation, when standing did not differ between the two groups. These data suggest that dynamic cerebral autoregulation is preserved in MSA. 相似文献